BaxΔ2 is a functional pro-apoptotic Bax isoform having alterations in its N-terminus, but sharing the rest of its sequence with Baxα. BaxΔ2 is unable to target mitochondria due to the loss of helix α1. Instead, it forms cytosolic aggregates and activates caspase 8. However, the functional domain(s) responsible for BaxΔ2 behavior have remained elusive. Here we show that disruption of helix α1 makes Baxα mimic the behavior of BaxΔ2. However, the other alterations in the BaxΔ2 N-terminus have no significant impact on aggregation or cell death. We found that the hallmark BH3 domain is necessary but not sufficient for aggregation-mediated cell death. We also noted that the core region shared by Baxα and BaxΔ2 is required for the formation of large aggregates, which is essential for BaxΔ2 cytotoxicity. However, aggregation by itself is unable to trigger cell death without the C-terminus. Interestingly, the C-terminal helical conformation, not its primary sequence, appears to be critical for caspase 8 recruitment and activation. As BaxΔ2 shares core and C-terminal sequences with most Bax isoforms, our results not only reveal a structural basis for BaxΔ2-induced cell death, but also imply an intrinsic potential for aggregate-mediated caspase 8-dependent cell death in other Bax family members.
The functional domains for BaxΔ2 aggregate-mediated caspase 8-dependent cell death Adriana The pro-apoptotic Bcl-2 family member Bax plays a crucial role in anti-tumorigenesis [1] [2] [3] [4] . Previous studies have shown that Bax possesses a significant "plasticity", as several functional Bax isoforms have been identified [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . The most prominent form of the Bax subfamily, Baxα, is ubiquitously expressed in most mammalian cells and has been well studied. Baxα has 6 exons that code for 192 amino acids. Its secondary structure is comprised of 9 alpha (α) helices with small unfolded regions in between to form a globular tertiary structure [15] . Several Baxα functional domains have been identified based on their similarities with other Bcl-2 family members. These include Bcl-2 homology domains: BH3 located in exon 3, BH1 in exon 4, and BH2 in the boundary region between exons 5 and 6 [1, 3, 4, 16] . The BH3 domain in all pro-death members, including the Bax subfamily, plays an essential role in inducing apoptosis. Structurally, the Baxα BH3 domain is part of a hydrophobic pocket formed mainly by helices α2, α5, and α6 encoded by exons 3, 4, and 5, respectively. The pocket is covered by helix α1, which is encoded mostly by exon 2 [15, [17] [18] [19] [20] .
The first 20 amino acids of the Bax N-terminal region, which do not share homology with any other member of the Bcl-2 family, conform a special domain known as Apoptosis-Regulating Targeting (ART). ART was initially believed to be a part of the mitochondrial targeting sequence, but later it has been shown to be not essential for mitochondrial targeting but critical for preventing Baxα from becoming activated in the absence of death signals [8, 9, [21] [22] [23] [24] [25] . The underlying mechanism is not fully understood, but it is believed that ART is responsible for maintaining the inactive monomeric form of Baxα proteins. Upon stimulation by cell death signals, Baxα monomers undergo conformational changes, form oligomers, and target mitochondria [26] [27] [28] [29] [30] [31] [32] [33] . Although the exact nature of the conformational changes is controversial, it is generally accepted that the death signalinduced exposure of the BH3 domain is critical for Baxα activation. It is also known that helices α2 to α6, encoded by exons 3-5, are required for Baxα oligomerization [29, [33] [34] [35] [36] , and helix α1 is essential for Baxα translocation to mitochondria [22, [37] [38] [39] . Recently, spectroscopic and scattering techniques have been used to identify the structures of the active Baxα monomer, dimer, and tetramer. These findings further support the concept that the displacement of helix α1 from the BH3-domain containing hydrophobic pocket is the first step for Baxα activation, leading to oligomerization and mitochondrial translocation [34] . The exact function of the Bax C-terminal region remains controversial. The Baxα C-terminal region has a transmembrane domain (TM) contained in helix α9 [15, 34, 40, 41] , which has been reported to play a critical role in targeting [2, 31, 42, 43] , anchoring, and penetrating the mitochondrial membrane [40, [44] [45] [46] . However, it has also been shown that alteration or deletion of the C-terminal region has little influence on the ability of Baxα to target mitochondria [22, 25, [47] [48] [49] [50] or its pro-apoptotic activity [25, 47, 48, 50] . Furthermore, although Baxβ, Baxσ, Baxϵ and Baxω isoforms have different C-termini, they all can release cytochrome C and trigger mitochondrial cell death in the same way as Baxα [5, 6, 12, 14] .
BaxΔ2 and its subfamily members are a group of unique functional Bax isoforms initially identified in patients with a family history of mismatch repair deficiency [13, [51] [52] [53] . BaxΔ2 has a guanine deletion in exon 3 (G8 → G7), which causes a frameshift and pre-mature termination of translation. However, an alternative splicing event removes most of exon 2 and restores the reading frame, resulting in a full-length functional isoform (BaxΔ2) with 10 new amino acids between the alternative splicing site and the point of the deletion. The rest of the BaxΔ2 sequence is the same as Baxα [13, 51, 53] .
BaxΔ2 is pro-apoptotic and still able to form dimers with Baxα and Bcl-2 [13] . However, BaxΔ2 is unable to target mitochondria due to the lack of helix α1 [13, 22, [37] [38] [39] . Instead, BaxΔ2 forms cytosolic aggregates, promoting apoptosis by activating caspase 8 [13, 51, 53] . However, the functional domain(s) for the aggregation and activation of caspase 8 were unknown. To understand the underlying molecular mechanism of BaxΔ2-induced apoptosis, we used computational structural modeling and cell-based approaches to analyze the functional domains that are responsible for its aggregation and cytotoxicity. Our results reveal that, apart from the impairment of mitochondrial translocation, the changes in the N-terminal of BaxΔ2, when compared to Baxα, seem to have no significant effect on its aggregation and cytotoxicity. The lack of helix α1 exposes the core of the protein and promotes BaxΔ2 to form cytosolic aggregates, which activate caspase 8 via the C-terminus in a helical structure-dependent manner to trigger cell death.
Materials and methods

Cloning
All BaxΔ2 constructs indicated in the text were generated using either Baxα or BaxΔ2 as a template for PCR-based cloning. The constructs were cloned by insertion of the corresponding PCR product in a pcDNA3.1 vector between EcoRI and KpnI sites. Each construct was in-frame tagged with a green fluorescence protein (GFP) at its Cterminus in the HindIII site. There is a 15-base pair linker between the construct and GFP gene. Deletions (Δ) were made and numbered according to the BaxΔ2 amino acid sequence. BaxΔ2[Δ13-21/G7] is a BaxΔ2 without the 10 new amino acids, while BaxΔ2[R13-21/G8] has the same 10 amino acids as Baxα (R representing replacement of the amino acids). An extra base pair was added to the latter to avoid a frameshift, which makes this construct equal to Baxα without exon 2. BaxΔ2[ARTΔ13-21/G7] is BaxΔ2 with a full-length ART sequence, but deletion of the 10 amino acids. BaxΔ2[Δ1-21] is BaxΔ2 with deletion of exon 1 and the 10 amino acids. This construct is basically Baxα without the first 2 exons. BaxΔ2[Δ13-61] is BaxΔ2 with complete deletion of exon 3, which could also be interpreted as Baxα without exons 2 and 3. An extra base pair was also added to this construct to avoid a frameshift. BaxΔ2[ΔBH3] is BaxΔ2 without the BH3 domain. BaxΔ2[Δ62-175] is BaxΔ2 without exons 4, 5, and 6. BaxΔ2[Δ110-175] is BaxΔ2 without exons 5 and 6. The beginning of the exon 5 sequence was retained to maintain the integrity of helix α5. BaxΔ2[Δ141-175] is BaxΔ2 without exon 6. C-terminal point-mutants were generated using the Transformer™ Site Directed Mutagenesis Kit (Clontech, Takara). All constructs were validated by DNA sequencing.
3D structure modeling and computational analyses
Structural models for BaxΔ2 and its mutant constructs were created using RaptorX [54] [55] [56] and I-TASSER [57] [58] [59] protein tertiary structure prediction server. Specifically, RaptorX first predicts the secondary structures, solvent accessibility, and disordered regions for the query sequence and then utilizes this information to search for templates through which to construct the 3D model of the query by Modeler [60] or Rosetta [61] . I-TASSER predicts the 3D model of the query sequence through four general steps: threading template identification, iterative structure assembly simulation, model selection, and refinement. Models obtained by different methods were compared and the structural similarity was determined as TM score (range between 0 and 1). Models of Baxα were also created and compared with the known structure as control. The disorder probability of the models was determined using PrDOS [62] . Analysis of conservative motifs between the C-terminal regions of BaxΔ2 and BaxΔ2ω was done with the assistance of the ClustalW server [63] . Helicity probability analysis was performed using NetSurfP 1.1 [64] and GOR4 [65] ; helicity probability values from both software programs were averaged, then values of BaxΔ2 were subtracted from each mutant construct's values before plotted.
Cell culture and transfection
The Bax negative colon cancer HCT116 subline cell line was generated as described previously [53] . All cells were cultured in Dulbecco's Modification of Eagle's Medium supplemented with 10% FBS. For transfection, cells were split in a 6-well plate, allowed to grow until 60% confluence, then transfected with the appropriate constructs, as indicated in the text, using Lipofectamine® 3000 Reagent (Invitrogen). Cells were then incubated for the time corresponding to each experiment. When required, cells were treated with 40 µM of Etoposide for 4 h.
Immunostaining and imaging
Bax-deficient MEFs were transfected on glass cover slides in a 6-well plate, incubated at 37°C for 16 h, then fixed with 4% paraformaldehyde and permeabilized with 0.2% Triton-X100 in Phosphate Buffered Saline (PBS). When required, cells were incubated overnight at 4°C with a primary antibody against Tom20 (Santa Cruz Biotechnologies, 1:100 dilution) or against caspase 8 (Cell Signaling, 1:100 dilution), followed by secondary antibody Alexa Fluor ® 594 (Life The experiments were performed in duplicate and results from at least three independent experiments were used for statistical analysis.
Immunoblotting
Bax negative HCT116 subline cells were transfected with BaxΔ2 derived constructs and incubated for 24 h. Cells were harvested and lysed in 0.1% NP-40 buffer containing 145 mM NaCl, 5 mM MgCl 2 , 20 mM HEPES, pH 7.4, 1 mM EDTA, 1 mM EGTA, 10 mM Dithiothreitol (DTT) and a cocktail of protease inhibitors including Aprotinin and Leupeptin. Protein concentration for each sample was measured and equal amounts of protein were loaded into a 12% SDS-PAGE gel and then transferred onto a 0.2 µm PVDF membrane. Membranes were blotted with 5% BSA, followed by incubation with a primary antibody against GFP (Santa Cruz Biotechnology, 1:1000 dilution) or actin (Millipore, 1:3000 dilution) overnight at 4°C. The membrane was washed with washing buffer (0.2% Tween ® 20 in PBS).
After incubation with HRP-conjugated secondary antibody (Jackson) for 1 h followed by several washes, the bands were visualized on X-ray films by a Pierce ® ECL Western Blotting Substrate developing kit (Thermo Scientific).
Statistical analysis
All values shown in the figures represent the mean ± SD. Statistical analysis was performed using R version 3.2.4 [66] . One-way ANOVA followed by Tukey's test was performed for all cell death experiments. Student t-test was used for the Caspase 8 inhibitor experiments. P values under 0.05 were considered significant.
Results
The loss of Helix α1 is responsible for the behavioral differences between Baxα and BaxΔ2
At the level of the coding sequence, BaxΔ2 differs from Baxα in its first three exons, while the rest of its sequence is the same as Baxα, including all BH domains (Fig. 1A) . To understand the structural basis that is responsible for the differences between BaxΔ2 and Baxα in terms of the mechanism of apoptosis, we predicted the BaxΔ2 structure based on the already known structure of Baxα [15] (Fig. 1B) . Although the results obtained from computational modeling for BaxΔ2 are completely theoretical, it provided a useful tool to help identify potential functional domains and guide the experimental design. The most striking structural difference between these two proteins appears to be in the N-terminus. BaxΔ2 seems to lack the majority of helix α1, which is encoded by exon 2 and a small part of exon 3 in Baxα ( Fig. 1B and C). In addition to the lack of helix α1, BaxΔ2 also has a shortened ART sequence (Fig. 1A) , which has been reported to have a negative regulatory role in Bax activation [8, 9, [21] [22] [23] [24] [25] . Furthermore, BaxΔ2 also has 10 new amino acids in the beginning of exon 3 resulted from an alternative splicing-caused frameshift. However, the original reading frame is restored at the microsatellite and maintained throughout the sequence ( Fig. 1A and C ). All these alterations seem to destabilize the N-terminal structure of BaxΔ2, as the structural disorder probability analysis using PrDOS [62] revealed that the N-terminal structure of BaxΔ2 was more disordered when compared with that of Baxα (Fig. 1D ). The known inactive Baxα structure is partially disordered in the first 15 amino acids but becomes ordered from amino acids 16-35, consistent with the presence of helix α1. By contrast, BaxΔ2 shows total disorder in the first 38 amino acids, which can be attributed to the sequence alterations in the first 3 exons (Fig. 1D) .
Previous studies by others have shown that disruption of helix α1 prevents Baxα from targeting mitochondria [22, [37] [38] [39] . Since the main difference between Baxα and BaxΔ2 is the helix α1, we hypothesized that disruption of the helical structure not only impairs Baxα's ability to target mitochondria but also could make Baxα behave like BaxΔ2. To test this, we analyzed a previously identified Bax mutation which significantly decreased Baxα's ability to target mitochondria (Leucine 26 to Glycine [L26G]), using the secondary structure prediction programs NetSurfP [64] and GOR4 [65] with Baxα wild type as control. We found that the mutant L26G seemed to cause disruption of helix α1 (Fig. 1E) . We then predicted the helicity of several other possible mutants within helix α1 (data not shown) and found that the double mutant, L26P/L27P, showed the highest disruption of helix α1 (Fig. 1E ). We generated L26P/L27P construct and transfected into Bax-negative HCT116 cells. The results from cell death assay showed that Baxα[L26P/L27P] mutant has a higher cytotoxicity than wild type Baxα and similar to BaxΔ2 ( Figure F) .
We next examined the cellular distribution and mitochondrial colocalization of the Baxα mutant (L26P/L27P). Bax-negative HCT116 cells were transfected with Baxα wild type, L26P/L27P, and BaxΔ2, and cells were treated with or without death stimulus (Etoposide) for 4 h. As shown in Fig. 1G , Baxα remained evenly distributed in the cell in the absence of a death signal, but co-localized with mitochondria upon Etoposide stimulation. However, L26P/L27P formed cytosolic aggregates regardless of Etoposide treatment. Furthermore, the aggregates in the L26P/L27P transfected cells were similar to those in BaxΔ2, heterogenic sizes and no co-localization with mitochondria (Fig. 1G) . These results further confirm that helix α1 is essential to target mitochondria, and disruption of the helical structure leads Baxα to have a BaxΔ2-like behavior.
The 10 new amino acids and shortened ART are not involved in BaxΔ2 aggregation and cytotoxicity
Once we confirmed that loss of helix α1 renders BaxΔ2 to the cytosol, the next step was to test what domains or regions of the protein are responsible for the new behavioral characteristics that are not seen in Baxα: aggregation and caspase 8 activation. To determine whether the 10 new amino acids and loss of part of the ART sequence (Fig. 1C) contributed to BaxΔ2 aggregation and cytotoxicity, we generated a series of BaxΔ2-derived constructs with variations in the N-terminus. The 10 new amino acids were either deleted or replaced with the original 10 amino acids from Baxα, in combination with deletion or restoration of the ART sequence ( Fig. 2A) . All constructs were tagged with GFP at their C-termini and transfected into Bax-negative human colon cancer subline HCT116 cells. Similar levels of expression of BaxΔ2 mutant proteins were detected by immunoblotting with anti-GFP antibody (Fig. 2B) . All transfectants showed similar levels of cytotoxicity ( Fig. 2C and D) when compared with full-length BaxΔ2. Interestingly, all BaxΔ2 mutants were capable of forming cytosolic aggregates, regardless of the N-terminal region alterations (Fig. 2E) . These results indicate that BaxΔ2 aggregation and cytotoxicity are likely independent of the new 10 amino acids and the shortened ART.
Bax BH3 domain is essential but not sufficient for BaxΔ2 aggregation and cytotoxicity
The above observations prompted us to determine which other (Fig. 3A) . The results showed that, although all BaxΔ2 mutants were expressed well (Fig. 3B ), none of them were able to induce apoptosis ( Fig. 3C and D) or form large cytosolic aggregates (Fig. 3E ). Of note, loss of the BH3 domain (ΔBH3) or exon 3 (Δ13-61) resulted in formation of evenly distributed fine granules, which appeared significantly smaller than those in BaxΔ2 when approximately measuring individual aggregates (Fig. 3F) . These results indicate that the BH3 domain is required for BaxΔ2 to form large aggregates and induce apoptosis. With the additional fact that the BaxΔ2[Δ62-175] mutant with an intact BH3 domain was unable to form aggregates at all or induce cell death, together, these data suggest that the BH3 domain is necessary but not sufficient for BaxΔ2 aggregation and cytotoxicity.
BaxΔ2 aggregation is necessary but not sufficient for its cytotoxicity
The finding that the BH3 domain is necessary but not sufficient for BaxΔ2 aggregation or cytotoxicity indicates that other regions of BaxΔ2 should be involved. To test this scenario, we generated a series of BaxΔ2 truncated mutants, which vary in exons 4-6 (Fig. 4A) . Although protein expression levels of these mutants were high in transfected cells (Fig. 4B) , none of the mutants were able to induce apoptosis compared to BaxΔ2 (Fig. 4C and D) . Interestingly, expression of the BaxΔ2 mutant protein missing only exon 6 forms much larger aggregates without inducing cell death (Fig. 4E, Δ141-175 and Fig. 4F ). This suggests that the BaxΔ2 C-terminal end is not essential for aggregation but critical for cell death. Thus, the critical domains involved in BaxΔ2 large aggregation are located in the core region of the BaxΔ2 protein encoded by exons 3-5, while the C-terminus encoded by exon 6 is essential for BaxΔ2 cytotoxicity.
BaxΔ2 C-terminus is required for caspase 8-activation in a primary sequence-independent manner
BaxΔ2 exon 6 is essential for aggregation-mediated toxicity and we previously showed that BaxΔ2-induced cell death is through activation of caspase 8 [53] . Next, we wanted to know which elements of the Cterminus were critical for the activation of caspase 8. To test this idea, we used BaxΔ2ω, a BaxΔ2 family member. Like BaxΔ2, BaxΔ2ω forms cytosolic aggregates to induce cell death [51] . However, BaxΔ2ω has a completely different C-terminus, due to a partial intron 5 retention caused by an alternative splicing event. The intron 5 retention in BaxΔ2ω causes a reading frame shift, resulting in a completely different sequence with an extended C-terminus (40 amino acids longer than BaxΔ2) (Fig. 5A) .
To test whether the C-terminus of BaxΔ2ω is essential for activation of caspase 8, we analyzed the cellular behavior of BaxΔ2ω in comparison with BaxΔ2. Co-localization analysis showed that, like BaxΔ2, BaxΔ2ω was able to form large aggregates, which were well colocalized with clusters of caspase 8 (Fig. 5B) . Consistently, both BaxΔ2 and BaxΔ2ω-induced cell death was significantly reduced by caspase 8 inhibitor (Fig. 5C ). To further confirm that recruitment and activation of caspase 8 rely on the C-terminus, we also examined the BaxΔ2 mutant lacking the C-terminus (BaxΔ2[Δ141-175]). Loss of the Cterminus did not affect BaxΔ2 ability to form aggregates (Fig. 4E ), but impaired its ability to recruit caspase 8 ( Fig. 5D ) and induce cell death (Fig. 5C ). These results suggest that BaxΔ2 recruitment and activation of caspase 8 rely on its C-terminus. However, such function seems to be independent of the primary amino acid sequence, as BaxΔ2ω behaves the same as BaxΔ2 even though they have distinct C-termini. Since the primary sequence of the C-terminus appears not to be essential, we hypothesize that the conserved motifs and structural domains may be responsible for the similar behavior of BaxΔ2 and BaxΔ2ω. To understand if the C-terminal region of BaxΔ2ω could form a structure similar to that of Baxα and BaxΔ2, we performed secondary and tertiary structure modeling analyses. While BaxΔ2 C-terminal structure is predicted to be the same as Baxα, presenting two helices, BaxΔ2ω is predicted to have four helices in its C-terminal region (Fig. 6A) . Three-dimensional structural modeling revealed the possibility of a conservative structural disposition in certain areas of the Cterminal region, despite the different number of helices (Fig. 6B) . Helix α8 from both proteins occupied the same space, and most of helix α9 of BaxΔ2 was well superimposed with helix α10 of BaxΔ2ω (Fig. 6B) . Analysis of the residue disorder probability using PrDOS [62] showed that both C-terminal regions had similar levels of disorder ( Fig. 6C and  D) . Taken together, these data suggest that the contribution of the Cterminus to BaxΔ2 cytotoxicity depends on conservative structural conformation, rather than the specific primary sequence. 3.6. BaxΔ2 C-terminal helix α9 is required for caspase 8-dependent cell death
To identify whether, within the predicted structurally conserved areas of the C-terminus, there are any motif(s) or residue(s) which are critical for caspase 8-dependent cell death, we performed further sequence alignment for the C-terminal regions of BaxΔ2 and BaxΔ2ω. The result showed that both proteins shared several con- served motifs, mostly clustered at the ends of helix α8 and α9 of BaxΔ2 (Fig. 7A) , consistent with the overlapping areas in the 3D prediction (Fig. 6B) . We then generated several mutants corresponding to key conservative residues ( Fig. 7A and B) . The ability of these mutants to form α helices was predicted using the secondary structure prediction programs NetSurfP [64] and GOR4 [65] , with BaxΔ2 as control (Fig. 7D) . Mutations at the end of helix α8 (L-A/S-A) seemed to have little effect on the C-terminal helicity. However, the single-point mutation L164P (L-P) in helix α9 appears to significantly disrupt the C-terminal helicity, as expected, due to proline's ability to destabilize alpha helices. Conversely, the L164A (LT-AA mutant) had no negative effect on the helicity. Similarly, abolishment of the positive charges at the end of helix α9 (KK-AA mutant) appeared to have no negative effect on the helicity, and instead seemed to increase the helix stability (Fig. 7D) .
To determine the cell death potentials of the above mutants, Bax negative HCT116 cells were transfected with the C-terminal GFP tagged mutants for 24 h. Expression of these mutant proteins was detected by immunoblotting with anti-GFP antibody, and the results showed that all mutant proteins were detected at similar or slightly higher levels compared to BaxΔ2 (Fig. 7C) . However, the degrees of cell death were significantly different (Fig. 7E) . Mutant L-A/S-A, which was predicted to have a minimal effect on helicity, had no significant effect on BaxΔ2 cell death (pink color in Fig. 7D and E) . Double mutant LT-AA in helix α9, with no negative effect on helicity, had a moderate decrease (~15%) in cell death (orange color), compared to BaxΔ2 (black color). A similar result was observed for mutant KK-AA, with abolishment of charged amino acids at the C-terminal end (yellow color). However, mutant L-P, with the highest predicted disruption in helicity, showed a drastic decrease in cell death (red color). Consistently, double mutant L-P/KK-AA (blue color), but not LT-AA/ KK-AA (green color), showed similar results as the L-P mutant (red color). Furthermore, as with BaxΔ2, the cell death caused by the toxic mutants could be significantly reduced by caspase 8 inhibitor (Fig. 7E) . These results indicate that disruption of helix α9 by a point-mutation significantly decreases the ability of BaxΔ2 to activate caspase 8. In summary, our results provide a structural and molecular basis that explains the behavior differences between Baxα and BaxΔ2. Disruption of helix α1 impairs Baxα ability to target mitochondria. Lack of helix α1 also prevents BaxΔ2 from targeting mitochondria, rendering it to cytosolic accumulation and leading to aggregation and cytotoxicity. The hallmark BH3-killing domain in BaxΔ2 is necessary but not sufficient both aggregation and cell death. The core region of the protein is required for both aggregation and cell death. However, aggregation itself is not sufficient to recruit caspase 8. The C-terminal helix α9 structure seems critical for recruitment and activation of the caspase 8, independently of the specific primary sequence (Fig. 8) .
Discussion
BaxΔ2 is a unique member of the Bax family [13, 51] . Unlike Baxα and other Bax family members that activate the canonical mitochondrial death pathway [1] [2] [3] [4] [5] [6] 8, 9, 12, 14] , BaxΔ2 aggregates in cytosol to activate caspase 8, which is normally involved in the receptor death pathway [53] . The underlying mechanism was previously unknown. Using the approach of computational analysis and structural modeling to help design cell based and biochemical experiments, we demonstrated that lack of helix α1 prevents BaxΔ2 from translocating to mitochondria. This leads to protein accumulation in the cytosol and the formation of large aggregates, which in turn utilize the C-terminal helical structure to activate the caspase 8-dependent death pathway (Fig. 8) .
Previous studies have shown that helix α1 is key for Baxα to translocate to mitochondria [22, [37] [38] [39] . In addition to confirming this result, we also showed that impairment of Baxα mitochondria targeting could result in its accumulation in the cytosol and formation of large aggregates, mimicking the behavior and cytotoxicity of BaxΔ2 (Fig. 1) . These observations seem to differ from a previous study, in which the Baxα L26G mutant also failed to target mitochondria, but remained evenly distributed in the cytosol with low toxicity [22] . The double mutant (L26P/L27P) not only impaired Baxα's ability to target mitochondria but also promoted its aggregation and caspase activation. A possible explanation could be extrapolated from our helicity prediction data. The double mutation decreased the helicity of helix α1 more significantly than the single mutation; the disruption of helix α1 in the single mutant L26G was enough to prevent it from targeting mitochondria but might not be enough to disrupt the inactive monomeric status of the protein in the absence of a death signal. Further studies are needed to test this hypothesis.
Loss of helix α1 is responsible for the BaxΔ2 protein accumulation in the cytosol, but by itself it cannot explain the other behavioral differences in comparison with Baxα, so we analyzed the rest of the protein to determine domains responsible for these differences. We found that the shortened ART and the 10 new amino acids did not contribute to the pro-apoptotic activity of BaxΔ2. Loss of exon 2 led to a shortened ART region in BaxΔ2 (Fig. 1) ; however, the complete restoration of ART was unable to inhibit BaxΔ2 pro-apoptotic activity (Fig. 2) . Absence or disruption of helix α1, seemed to result in constitutive activation regardless of the presence of ART. Little is known about the underlying mechanism of ART regulatory function, but our results suggest that it might be dependent on helix α1. Therefore, as helix α1 no longer exists in BaxΔ2, it leaves ART with no significant function in this isoform. Interestingly, the removal of the 10 new amino acids also had no significant effect on BaxΔ2 aggregation or cytotoxicity, and neither did the restoration of the original 10 amino acids (Fig. 2) . Since neither ART nor the 10 new amino acids affect the aggregation or pro-apoptotic activity, BaxΔ2 appears to be equivalent to Baxα without exon 2, since the rest of the sequence is the same. Indeed, both Baxα with disrupted helix α1 (Baxα[L26P/L27P]) and Baxα lacking only exon 2 (BaxΔ2[R13-21/G8]) had the same degree of aggregation and cell death as BaxΔ2 (Figs. 1 and 2 ). In Baxα, helix α1 covers the core region of the protein and, upon cell death signal stimulation, helix α1 is unlatched from its position and exposes the core region, which is critical for the formation of Baxα oligomers [29, [33] [34] [35] [36] . Therefore, transition from inactive to active form is needed for exerting Baxα-induced cell death. BaxΔ2, however, seems to be already in its active form regardless of death signal status. Of note, unlike Baxα, BaxΔ2 proteins are extremely unstable and susceptible to proteasomal degradation. We have also shown that BaxΔ2 is capable of binding both Baxα and Bcl-2 [13] . Whether combination of fast degradation and association with other proteins can withhold BaxΔ2 activity under endogenous expression conditions remains to be explored. Another interesting notion is that, although active Baxα proteins can form oligomers in cytosol [34] , they do not form large aggregates. This is most likely because Baxα proteins immediately translocate to mitochondria upon activation. Therefore, we propose that BaxΔ2 aggregation is not a gain-of-function, but an inherent consequence of its inability to target mitochondria. Sequentially, these large aggregates may serve as a platform to recruit and activate caspase 8 for cell death. The heterogeneously sized aggregates we observed were largely insoluble and could not be dissolved by detergents like NP-40 or Triton X-100, thereby remaining as insoluble precipitates that could be easily visualized under a fluorescent microscope (data not shown). This makes it practically impossible to analyze the size of these aggregates through conventional biochemical methods such as FPLC. Also, the high levels of aggregation combined with its high toxicity, even with a bacterial expression system, have made it very difficult to isolate enough soluble BaxΔ2 protein for experimental structural analyses such as NMR or CD.
Despite the difficulties to determine the size and structural nature of the BaxΔ2 aggregates, we discovered that aggregation is necessary, but by itself, not sufficient to induce apoptosis. BaxΔ2 aggregation and cell death are highly interconnected, as blocking aggregation also abolished cell death (Figs. 3 and 4) . However, aggregation alone was not sufficient to lead to apoptosis. The BaxΔ2 mutant missing its Cterminus was able to accumulate exceptionally large aggregates in cytosol, but failed to induce significant cell death (Fig. 4, Δ141-175 ). This suggests that the C-terminus is critical for the recruitment of caspase 8 to the aggregates. Among the C-terminus, the helical structure, and not the primary sequence, appears to be essential for this function. BaxΔ2ω, another member of the Bax family, behaves exactly the same as BaxΔ2 despite having a completely different Cterminal sequence (Figs. 5 and 6 ). Also, disruption of helix α9 by single point mutation (L164P) significantly impaired caspase 8-dependent cell death (Fig. 7) . Of note, disruption of helix α9 did not totally abolish cell death, around 25% of caspase 8-independent cell death remained (Fig. 7E) . Similar degrees of cell death were also observed in BaxΔ2 and BaxΔ2ω when treated with Caspase 8 inhibitor (Fig. 5C ). These data, along with the result from the construct missing exon 6 (Fig. 4, Δ141-175) , indicate that the remaining cell death might be contributed by caspase 8-independent toxicity, probably resulting from high levels of protein aggregation.
We do not exclude out the possibility that truncations, especially large truncations, could cause protein misfolding or unfolding resulting Fig. 8 . Proposed functional domains for BaxΔ2-induced cell death. Graphical summary of the differences in cell death mechanisms between Baxα and BaxΔ2 and the critical domains for BaxΔ2 aggregation-mediated caspase 8-dependent cell death. ART plays a regulatory role in Baxα, but no apparent function in BaxΔ2. Helix α1 is responsible for Baxα to target mitochondria, but its absence renders BaxΔ2 to the cytosol. The core region of the protein, encoded by exons 3-5 and containing the BH3 and BH1 domains, is known to be responsible for Baxα oligomerization, and is also critical for aggregation of BaxΔ2. The role of C-terminal region, specially the helix α9, still remains controversial for Baxα, but seems essential for BaxΔ2-induced caspase 8-mediated cell death.
A. Mañas et al. Experimental Cell Research 359 (2017) [342] [343] [344] [345] [346] [347] [348] [349] [350] [351] [352] [353] [354] [355] in the loss of its function despite having the necessary domains. However, this seems unlikely in this case. For the C-terminal truncation (BaxΔ2[Δ145-175]), the behavior of the truncated protein was very similar to that with a single-point mutation (L164P). Consistently, for the N-terminal truncation, loss of helix α1 showed a similar behavior as that of the point-mutation (L26P/L27P), both lost the ability to target mitochondria but gained the ability to aggregate and activate caspase 8-dependent cell death. It is worth to mention that, although the behavior of aggregation and cytotoxicity are similar, there is a possibility that the exact underlying mechanisms in some constructs might be different. Nevertheless, it is clear that the intrinsic function of BaxΔ2 relies on its internal structure, rather than being a result of misfolding or unfolding of the protein.
Based on all these results, we propose that upon aggregate formation, the BaxΔ2 C-terminus serves as an adaptor to recruit caspase 8 and bring them to close proximity for activation. However, where and how helix α9 interacts with caspase 8 remains to be solved. The sequence or structural homology of the C-terminal is shared by many Bax family members such as Baxα, Baxσ, Baxψ and Baxω, in addition to the BaxΔ2 subfamily. Although most, if not all, Bax family members do not usually require caspase 8 for cell death, our results imply the possibility that the Bax family members may have an intrinsic ability to activate the caspase 8 pathway if they fail to target mitochondria. Future studies are needed to explore this possibility. Undoubtedly, the "plasticity" of the Bax family is crucial to ensure its pro-death role in both canonical and noncanonical cell death.
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